Literature DB >> 25779968

A cell-penetrating ester of the neural metabolite lanthionine ketimine stimulates autophagy through the mTORC1 pathway: Evidence for a mechanism of action with pharmacological implications for neurodegenerative pathologies.

Marni E Harris-White1, Kathie G Ferbas2, Ming F Johnson3, Pirooz Eslami3, Aleksandra Poteshkina3, Kalina Venkova4, Alexandar Christov4, Kenneth Hensley5.   

Abstract

Autophagy is a fundamental cellular recycling process vulnerable to compromise in neurodegeneration. We now report that a cell-penetrating neurotrophic and neuroprotective derivative of the central nervous system (CNS) metabolite, lanthionine ketimine (LK), stimulates autophagy in RG2 glioma and SH-SY5Y neuroblastoma cells at concentrations within or below pharmacological levels reported in previous mouse studies. Autophagy stimulation was evidenced by increased lipidation of microtubule-associated protein 1 light chain 3 (LC3) both in the absence and presence of bafilomycin-A1 which discriminates between effects on autophagic flux versus blockage of autophagy clearance. LKE treatment caused changes in protein level or phosphorylation state of multiple autophagy pathway proteins including mTOR; p70S6 kinase; unc-51-like-kinase-1 (ULK1); beclin-1 and LC3 in a manner essentially identical to effects observed after rapamycin treatment. The LKE site of action was near mTOR because neither LKE nor the mTOR inhibitor rapamycin affected tuberous sclerosis complex (TSC) phosphorylation status upstream from mTOR. Confocal immunofluorescence imaging revealed that LKE specifically decreased mTOR (but not TSC2) colocalization with LAMP2(+) lysosomes in RG2 cells, a necessary event for mTORC1-mediated autophagy suppression, whereas rapamycin had no effect. Suppression of the LK-binding adaptor protein CRMP2 (collapsin response mediator protein-2) by means of shRNA resulted in diminished autophagy flux, suggesting that the LKE action on mTOR localization may occur through a novel mechanism involving CRMP2-mediated intracellular trafficking. These findings clarify the mechanism-of-action for LKE in preclinical models of CNS disease, while suggesting possible roles for natural lanthionine metabolites in regulating CNS autophagy.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; CRMP2; DPYSL2; Lanthionine ketimine; mTOR complex (mTORC)

Mesh:

Substances:

Year:  2015        PMID: 25779968      PMCID: PMC4569546          DOI: 10.1016/j.nbd.2015.03.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  53 in total

1.  Developmental and activity-dependent expression of LanCL1 confers antioxidant activity required for neuronal survival.

Authors:  Chao Huang; Mina Chen; Dejiang Pang; Dandan Bi; Yi Zou; Xiaoqiang Xia; Weiwei Yang; Liping Luo; Rongkang Deng; Honglin Tan; Liang Zhou; Shouyang Yu; Liheng Guo; XiaoXia Du; Yiyuan Cui; Jiahua Hu; Qing Mao; Paul F Worley; Bo Xiao
Journal:  Dev Cell       Date:  2014-08-25       Impact factor: 12.270

2.  The serine/threonine kinase ULK1 is a target of multiple phosphorylation events.

Authors:  Markus Bach; Mark Larance; David E James; Georg Ramm
Journal:  Biochem J       Date:  2011-12-01       Impact factor: 3.857

3.  Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function.

Authors:  Kristin P Bibee; Ya-Jian Cheng; James K Ching; Jon N Marsh; Allison J Li; Richard M Keeling; Anne M Connolly; Paul T Golumbek; Jacob W Myerson; Grace Hu; Junjie Chen; William D Shannon; Gregory M Lanza; Conrad C Weihl; Samuel A Wickline
Journal:  FASEB J       Date:  2014-02-05       Impact factor: 5.191

4.  mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action.

Authors:  Ghada A Soliman; Hugo A Acosta-Jaquez; Elaine A Dunlop; Bilgen Ekim; Nicole E Maj; Andrew R Tee; Diane C Fingar
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

5.  Identification of lanthionine synthase C-like protein-1 as a prominent glutathione binding protein expressed in the mammalian central nervous system.

Authors:  Charlotte H Y Chung; Biji T Kurien; Padmaja Mehta; Molina Mhatre; Shenyun Mou; Quentin N Pye; Charles Stewart; Melinda West; Kelly S Williamson; Jan Post; Lucy Liu; Rachel Wang; Kenneth Hensley
Journal:  Biochemistry       Date:  2007-02-17       Impact factor: 3.162

6.  Collapsin response mediator protein-2 (Crmp2) regulates trafficking by linking endocytic regulatory proteins to dynein motors.

Authors:  Juliati Rahajeng; Sai S P Giridharan; Naava Naslavsky; Steve Caplan
Journal:  J Biol Chem       Date:  2010-08-27       Impact factor: 5.157

7.  Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome.

Authors:  Suchithra Menon; Christian C Dibble; George Talbott; Gerta Hoxhaj; Alexander J Valvezan; Hidenori Takahashi; Lewis C Cantley; Brendan D Manning
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

8.  Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders.

Authors:  Rajesh Khanna; Sarah M Wilson; Joel M Brittain; Jill Weimer; Rukhsana Sultana; Allan Butterfield; Kenneth Hensley
Journal:  Future Neurol       Date:  2012-11-01

9.  Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis.

Authors:  Melanie Thelen; Markus Damme; Markus Daμμe; Michaela Schweizer; Christian Hagel; Andrew M S Wong; Jonathan D Cooper; Thomas Braulke; Giovanna Galliciotti
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

10.  Impaired autophagy flux is associated with neuronal cell death after traumatic brain injury.

Authors:  Chinmoy Sarkar; Zaorui Zhao; Stephanie Aungst; Boris Sabirzhanov; Alan I Faden; Marta M Lipinski
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

View more
  10 in total

1.  Mild mitochondrial metabolic deficits by α-ketoglutarate dehydrogenase inhibition cause prominent changes in intracellular autophagic signaling: Potential role in the pathobiology of Alzheimer's disease.

Authors:  Kalpita Banerjee; Soumyabrata Munshi; Hui Xu; David E Frank; Huan-Lian Chen; Charleen T Chu; Jiwon Yang; Sunghee Cho; Valerian E Kagan; Travis T Denton; Yulia Y Tyurina; Jian Fei Jiang; Gary E Gibson
Journal:  Neurochem Int       Date:  2016-02-23       Impact factor: 3.921

2.  Effects of Lanthionine Ketimine-5-Ethyl Ester on the α-Synucleinopathy Mouse Model.

Authors:  Arina Yazawa; Kenneth Hensley; Toshio Ohshima
Journal:  Neurochem Res       Date:  2022-05-19       Impact factor: 4.414

3.  Multiple-step, one-pot synthesis of 2-substituted-3-phosphono-1-thia-4-aza-2-cyclohexene-5-carboxylates and their corresponding ethyl esters.

Authors:  Dunxin Shen; Kenneth Hensley; Travis T Denton
Journal:  Bioorg Med Chem Lett       Date:  2018-02-01       Impact factor: 2.823

Review 4.  Impaired Autophagy in Motor Neurons: A Final Common Mechanism of Injury and Death.

Authors:  Maria A Gonzalez Porras; Gary C Sieck; Carlos B Mantilla
Journal:  Physiology (Bethesda)       Date:  2018-05-01

Review 5.  Reciprocal Control of Thyroid Binding and the Pipecolate Pathway in the Brain.

Authors:  André Hallen; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2016-08-12       Impact factor: 3.996

Review 6.  An overview of sulfur-containing compounds originating from natural metabolites: Lanthionine ketimine and its analogues.

Authors:  Dunxin Shen; Kenneth Hensley; Travis T Denton
Journal:  Anal Biochem       Date:  2019-12-17       Impact factor: 3.365

Review 7.  H2S- and NO-Signaling Pathways in Alzheimer's Amyloid Vasculopathy: Synergism or Antagonism?

Authors:  Alla B Salmina; Yulia K Komleva; István A Szijártó; Yana V Gorina; Olga L Lopatina; Galina E Gertsog; Milos R Filipovic; Maik Gollasch
Journal:  Front Physiol       Date:  2015-12-11       Impact factor: 4.566

Review 8.  Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.

Authors:  Kenneth Hensley; Petri Kursula
Journal:  J Alzheimers Dis       Date:  2016-04-15       Impact factor: 4.472

9.  The DPYSL2 gene connects mTOR and schizophrenia.

Authors:  X Pham; G Song; S Lao; L Goff; H Zhu; D Valle; D Avramopoulos
Journal:  Transl Psychiatry       Date:  2016-11-01       Impact factor: 6.222

Review 10.  The Sulfur Metabolite Lanthionine: Evidence for a Role as a Novel Uremic Toxin.

Authors:  Alessandra F Perna; Miriam Zacchia; Francesco Trepiccione; Diego Ingrosso
Journal:  Toxins (Basel)       Date:  2017-01-10       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.